Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I.
about
Carfilzomib Triple Combination Therapy: A Review in Relapsed Multiple Myeloma.Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma.Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progressionElotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling.
P2860
Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Carfilzomib enhances natural k ...... ing expression of HLA class I.
@ast
Carfilzomib enhances natural k ...... ing expression of HLA class I.
@en
type
label
Carfilzomib enhances natural k ...... ing expression of HLA class I.
@ast
Carfilzomib enhances natural k ...... ing expression of HLA class I.
@en
prefLabel
Carfilzomib enhances natural k ...... ing expression of HLA class I.
@ast
Carfilzomib enhances natural k ...... ing expression of HLA class I.
@en
P2093
P2860
P356
P1433
P1476
Carfilzomib enhances natural k ...... sing expression of HLA class I
@en
P2093
Guang Yang
Hongwei Xu
Minjie Gao
Xiaosong Wu
Xiuqin Meng
Yiwen Zhang
P2860
P304
26982-26994
P356
10.18632/ONCOTARGET.4831
P407
P577
2015-09-01T00:00:00Z